Company news

Immuron Limited news in 2021

Immuron Limited's news releases, calls and decks from 2021, newest first.

View company

US DoD Travelan Clinical Update

November 14, 2021

US DoD Naval Medical Research Center Clinical Update

November 9, 2021

IMM124E Demonstrates Antiviral T-Cell Immunity

October 8, 2021

Reinstatement to Official Quotation

September 23, 2021

Immuron planned Acquisition of R&D Vaccine Company

September 23, 2021

Preliminary Final Report

August 31, 2021

Voluntary Suspension

May 30, 2021

Pause in Trading

May 27, 2021

IMM124E May Offer New Modality for Inhibition of SARS-CoV-2

May 12, 2021

Decks in 2021